Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications

Michelle Roytman1, David J Pisapia2, Benjamin Liechty2

  • 1Department of Radiology, Weill Cornell Medicine-New York Presbyterian Hospital, United States of America.

Clinical Imaging
|May 23, 2020
PubMed
Summary

This study details an atypical meningioma that showed low uptake on Gallium-68 DOTATATE PET/MRI. Immunohistochemistry confirmed it was somatostatin receptor subtype 2 (SSTR2)-negative, challenging typical imaging findings.